- Home
- HBANZ vs HUMAW Comparison
HBANZ vs HUMAW Comparison
Compare HBANZ & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HBANZ
Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/1000th Interest in a Share of 5.50% Series L Non-Cumulative Perpetual Preferred Stock
Current Price
Company Overview
Basic Information| Metric | HBANZ | HUMAW |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | 24641 | 184 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HBANZ | HUMAW |
|---|---|---|
| Price | $20.42 | $0.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.4K | ★ 14.2K |
| Earning Date | N/A | 03-21-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.35 | $0.04 |
| 52 Week High | $22.23 | $0.60 |
Technical Indicators
Market Signals| Indicator | HBANZ | HUMAW |
|---|---|---|
| Relative Strength Index (RSI) | 32.42 | 49.37 |
| Support Level | $20.35 | $0.08 |
| Resistance Level | $21.36 | $0.12 |
| Average True Range (ATR) | 0.17 | 0.01 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 7.14 | 50.94 |
Price Performance
Historical ComparisonAbout HBANZ Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/1000th Interest in a Share of 5.50% Series L Non-Cumulative Perpetual Preferred Stock
Huntington is a regional US bank with over $285 billion in assets. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.